Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hypoxia 3 Prostatic Neoplasms 2 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Melanoma 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 16 Cetuximab 16 Radiotherapy, Intensity-Modulated 10 Radiotherapy 7 Docetaxel 7 Fluorouracil 5 Erlotinib Hydrochloride 5 Everolimus 4 Carboplatin 4 Sorafenib 3 Paclitaxel 3 Fluorodeoxyglucose F18 3 Chemotherapy, Adjuvant 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 Ultrasonography 2 Taxes 2 Sirolimus 2 Radiotherapy, Conformal 2 Radiation 2 Platinum 2 Photochemotherapy 2 Magnetic Resonance Spectroscopy 2 Cryosurgery 2 Celecoxib 2 Biopsy 2 Bevacizumab 2 1-phenyl-3,3-dimethyltriazene 2 1,2-diaminocyclohexaneplatinum II citrate 2 temsirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tongue Neoplasms × pimonidazole × Clear all

NCT03181035 2024-08-12

FAITH

Sunnybrook Health Sciences Centre

Phase 1/2 Suspended

Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡